Recovery Reimagined
Transforming Injury Recovery
Injuries to tendons and ligaments have long been a significant challenge in both human and equine health. Traditional treatments often fall short, leading to prolonged recovery times, limited effectiveness, and a high risk of recurrence.
Diagnosing and monitoring these injuries have relied on outdated methods, leaving both athletes and their equine counterparts in a perpetual struggle for effective solutions.
Diagnosing and monitoring these injuries have relied on outdated methods, leaving both athletes and their equine counterparts in a perpetual struggle for effective solutions.
Regenall's Vision for a Revolutionary Future:
Regenall aims to revolutionize tendon and ligament treatment, surpassing traditional methods. Our mission is to inhibit scar tissue and promote the growth of functional tissue, paving the way for a future where technology and science redefine recovery approaches. Join us on this transformative journey.
The Regenall Healing Process
1
Before Regenall
No Improvement
Horses prior to administration of Regenall 15 months post-chronic tendon/ligament injuries showed only minimal improvement in lesion size and echogenicity of the injured tendon.
2
After Regenall
Healing
By 14 weeks the lesion size more than halved
Echogenicity
(Regeneration & Strength)
(Regeneration & Strength)
By 14 weeks the tendon had regained 80% of its normal strength
3
Continual Treatment
Prolonged Treatment
Prolonged treatment with Regenall:
- Complete healing;
- 100% of normal strength regained;
Pioneering Recovery: Exploring the cutting-edge tendon and ligament healing in human.
Explore the intricate phases of tendon and ligament healing, unraveling the science behind Regenall™ and its transformative impact on the body's natural repair processes.
Injury Initiation
Disruption of tendon tissue triggers wound repair processes, similar to skin injuries. Intrinsic and extrinsic processes contribute to repair.
General Case in Tendon Injury Recovery
Acute Phase (1-2 weeks):
- Disruption of tendon tissue triggers wound repair processes, similar to skin injuries.
- Intrinsic and extrinsic processes contribute to repair.
Case in Tendon Injury Recovery With Regenall™ Intervention
Acute Phase (1-2 weeks):
- Regenall™ treatment moderates inflammation.
- Aims to enhance the subsequent fibrous repair process.
Subacute Phase (Few days to months):
- Fibroblastic response lays down fibrous scar tissue.
- Restores mechanical strength weakened by the injury.
Subacute Phase (Few days to months):
- Regenall™ accelerates the laying down of fibrous scar tissue.
- Focuses on restoring mechanical strength efficiently.
Chronic Phase (Many months):
- Scar tissue undergoes remodeling to improve functional properties.
- Structurally strong but less functional tendon tissue may result, increasing the risk of re-injury.
Chronic Phase (Many months):
- Regenall™ facilitates optimal remodeling of scar tissue.
- Aims to maintain both structural strength and functionality.
Injury Initiation
Disruption of tendon tissue triggers wound repair processes, similar to skin injuries. Intrinsic and extrinsic processes contribute to repair.
General Case in Tendon Injury Recovery
Acute Phase (1-2 weeks):
- Disruption of tendon tissue triggers wound repair processes, similar to skin injuries.
- Intrinsic and extrinsic processes contribute to repair.
Subacute Phase (Few days to months):
- Fibroblastic response lays down fibrous scar tissue.
- Restores mechanical strength weakened by the injury.
Chronic Phase (Many months):
- Scar tissue undergoes remodeling to improve functional properties.
- Structurally strong but less functional tendon tissue may result, increasing the risk of re-injury.
Injury Initiation with Regenall
Disruption of tendon tissue triggers wound repair processes, similar to skin injuries. Intrinsic and extrinsic processes contribute to repair.
Case in Tendon Injury Recovery With Regenall™ Intervention
Acute Phase (1-2 weeks):
- Regenall™ treatment moderates inflammation.
- Aims to enhance the subsequent fibrous repair process.
Subacute Phase (Few days to months):
- Regenall™ accelerates the laying down of fibrous scar tissue.
- Focuses on restoring mechanical strength efficiently.
Chronic Phase (Many months):
- Regenall™ facilitates optimal remodeling of scar tissue.
- Aims to maintain both structural strength and functionality.
Scientific Validation and Study Results
A Chronological Examination of Lesion Size and Echogenicity from Injury Onset to Post-Maintenance Dose
Time of Original Injury Week
9 months prior to starting
Lesion size = 51.6% of SOFT
Echogenicity (lesion vs healthy) = 68.1%
Echogenicity (lesion vs healthy) = 68.1%
Week 0
Lesion size = 64.9%
Echogenicity (lesion vs healthy)= 53.9%
Echogenicity (lesion vs healthy)= 53.9%
Immediately Prior to Commencing
There is a large lesion in the superficial flexor tendon. Both the tendon and the lesion are outlined in red
Week 3
Lesion size = 66.5%
Echogenicity (lesion vs healthy)= 54.5%
Echogenicity (lesion vs healthy)= 54.5%
Week 5
Lesion size = 53.8%
Echogenicity (lesion vs healthy)= 55.5%
Echogenicity (lesion vs healthy)= 55.5%
Week 7
Lesion size = 49.2%
Echogenicity (lesion vs healthy)= 65.9%
Echogenicity (lesion vs healthy)= 65.9%
Week 14
Lesion size = 27.4%
Echogenicity (lesion vs healthy)= 76.4%
Echogenicity (lesion vs healthy)= 76.4%
After Maintenance Dose
why us?
Results
HEALING:
Lesion size is more than halved with Regenall™.
STRENGTH:
Regenall™ indicates an improvement in strength up to a mean of 80%
CLEAR IMPACT:
Placebo horses with pre-existing injuries show no improvement.
PROLONGED TREATMENT:
Complete healing, with 100% of normal strength regained.
Quote
Regenall prolongs the active lifetime of any individual, no matter the intensity of lifestyle
let's talk
Have any questions?
Have you experienced tendon or ligament injuries in yourself or your horse? Let's discuss.
Elevating Equine and Human Tendon and
Ligament Care to New Heights
Ligament Care to New Heights
COPYRIGHT © 2024 — REGENALL